Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
November 16, 2006
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
S Franceschi, J Polesel, M Rickenbach, et al.
HIV Medicine
|
March 25, 2018
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men
K Aebi-Popp, G Wandeler, L Salazar-Vizcaya, et al.
AIDS Research and Human Retroviruses
|
September 22, 2010
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy
L Magenta, S Dell-Kuster, W O Richter, et al.
HIV Medicine
|
October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
J Young, A U Scherrer, H F Günthard, et al.
HIV Medicine
|
March 2, 2017
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study
H M Gebreselassie, D Kraus, C A Fux, et al.
HIV Medicine
|
July 3, 2015
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
V Schaerer, S Haubitz, H Kovari, et al.
HIV Medicine
|
August 14, 2015
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period
K Aebi-Popp, R Kouyos, B Bertisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 12, 2024
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study
M S R Weber, J J Duran Ramirez, M Hentzien, et al.
The Journal of Antimicrobial Chemotherapy
|
May 14, 2014
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals
M Arab-Alameddine, R Lubomirov, A Fayet-Mello, et al.
HIV Medicine
|
December 29, 2019
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
M Metral, I Nadin, I Locatelli, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
November 16, 2006
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
S Franceschi, J Polesel, M Rickenbach, et al.
HIV Medicine
|
March 25, 2018
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men
K Aebi-Popp, G Wandeler, L Salazar-Vizcaya, et al.
AIDS Research and Human Retroviruses
|
September 22, 2010
Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy
L Magenta, S Dell-Kuster, W O Richter, et al.
HIV Medicine
|
October 20, 2010
Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients: the Swiss HIV Cohort Study
J Young, A U Scherrer, H F Günthard, et al.
HIV Medicine
|
March 2, 2017
Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study
H M Gebreselassie, D Kraus, C A Fux, et al.
HIV Medicine
|
July 3, 2015
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake
V Schaerer, S Haubitz, H Kovari, et al.
HIV Medicine
|
August 14, 2015
Postnatal retention in HIV care: insight from the Swiss HIV Cohort Study over a 15-year observational period
K Aebi-Popp, R Kouyos, B Bertisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 12, 2024
Time Trends in Causes of Death in People With HIV: Insights From the Swiss HIV Cohort Study
M S R Weber, J J Duran Ramirez, M Hentzien, et al.
The Journal of Antimicrobial Chemotherapy
|
May 14, 2014
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals
M Arab-Alameddine, R Lubomirov, A Fayet-Mello, et al.
HIV Medicine
|
December 29, 2019
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
M Metral, I Nadin, I Locatelli, et al.
Page
of 8